|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 37284 |
FusionGeneSummary for TATDN2_FANCD2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TATDN2_FANCD2 | Fusion gene ID: 37284 | Hgene | Tgene | Gene symbol | TATDN2 | FANCD2 | Gene ID | 9797 | 2177 |
| Gene name | TatD DNase domain containing 2 | FA complementation group D2 | |
| Synonyms | - | FA-D2|FA4|FACD|FAD|FAD2|FANCD | |
| Cytomap | 3p25.3 | 3p25.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | putative deoxyribonuclease TATDN2 | Fanconi anemia group D2 proteinFanconi anemia complementation group D2 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q93075 | Q9BXW9 | |
| Ensembl transtripts involved in fusion gene | ENST00000287652, ENST00000448281, ENST00000496355, | ENST00000287647, ENST00000383807, ENST00000383806, ENST00000419585, ENST00000431693, ENST00000438741, | |
| Fusion gene scores | * DoF score | 4 X 3 X 4=48 | 3 X 3 X 3=27 |
| # samples | 4 | 3 | |
| ** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: TATDN2 [Title/Abstract] AND FANCD2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FANCD2 | GO:0010332 | response to gamma radiation | 12874027 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | ESCA | TCGA-L5-A4OQ-01A | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000287652 | ENST00000287647 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000287652 | ENST00000383807 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-3UTR | ENST00000287652 | ENST00000383806 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-3UTR | ENST00000287652 | ENST00000419585 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000287652 | ENST00000431693 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000287652 | ENST00000438741 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000448281 | ENST00000287647 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000448281 | ENST00000383807 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-3UTR | ENST00000448281 | ENST00000383806 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-3UTR | ENST00000448281 | ENST00000419585 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000448281 | ENST00000431693 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| 5CDS-intron | ENST00000448281 | ENST00000438741 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-intron | ENST00000496355 | ENST00000287647 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-intron | ENST00000496355 | ENST00000383807 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-3UTR | ENST00000496355 | ENST00000383806 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-3UTR | ENST00000496355 | ENST00000419585 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-intron | ENST00000496355 | ENST00000431693 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
| intron-intron | ENST00000496355 | ENST00000438741 | TATDN2 | chr3 | 10291298 | + | FANCD2 | chr3 | 10142872 | + |
Top |
FusionProtFeatures for TATDN2_FANCD2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TATDN2 | FANCD2 |
| Putative deoxyribonuclease. {ECO:0000250}. | Required for maintenance of chromosomal stability.Promotes accurate and efficient pairing of homologs duringmeiosis. Involved in the repair of DNA double-strand breaks, bothby homologous recombination and single-strand annealing. Mayparticipate in S phase and G2 phase checkpoint activation upon DNAdamage. Plays a role in preventing breakage and loss ofmissegregating chromatin at the end of cell division, particularlyafter replication stress. Required for the targeting, orstabilization, of BLM to non-centromeric abnormal structuresinduced by replicative stress. Promotes BRCA2/FANCD1 loading ontodamaged chromatin. May also be involved in B-cell immunoglobulinisotype switching. {ECO:0000269|PubMed:11239453,ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603,ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836,ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022,ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491,ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754,ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TATDN2_FANCD2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TATDN2_FANCD2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| TATDN2 | BRCA1, MOV10, NXF1, SPACA1, MRPL4, PLAUR, CCNJL, FBXW11 | FANCD2 | TNFRSF1A, TNFRSF1B, ATM, BLM, BRCA2, NBN, MEN1, BRCA1, FANCE, KAT5, USP1, RAD18, TNKS, TERF1, POLN, CEBPD, IPO4, FAN1, FOXO3, H2AFX, PCNA, FANCI, DCLRE1B, FANCG, ATR, FANCC, MYC, MDC1, ELAVL1, MSH2, MLH1, UBC, FANCL, POLH, CDK20, DNM1, IRF2BPL, DCP2, FZR1, RBBP8, TNFSF13B, CA14, P2RY8, PTGER3, ALDH3A2, KPNA1, NTRK1, MUS81, FBXW7, UBE2T, CDC42, EPHA2, HNRNPD, YEATS4, JRKL, EMC2, ITGB3BP, PIGS, CNTROB, BAG6, RAD51, REV1, CDC5L, POU5F1, CHEK1, TPTE, LPAR4, FANCA, CTBP1, RUNX3, RUNX1, DNA2, BRIP1, LAMB2, MCM2, MCM3, MCM4, HELQ, ATP5A1, PRKDC, ERCC4, RPA1, SLX4, PARP1, PARP2, TOP3A, SPTAN1, SPTA1, AKT1, MCM6, MCM5, MCM7, HIST1H3A, HIST1H4A, HIST1H2AB, HIST1H2BB, ABCB6, UHRF2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TATDN2_FANCD2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TATDN2_FANCD2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | FANCD2 | C0015625 | Fanconi Anemia | 1 | CTD_human;ORPHANET |
| Tgene | FANCD2 | C3160738 | FANCONI ANEMIA, COMPLEMENTATION GROUP D2 | 1 | CTD_human;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|